Dose Creep During a Long Fluoroscopic Case
Mr. D is a 78-year-old man (BMI 42) undergoing a complex fluoroscopically guided biliary procedure. Total fluoroscopy time reaches 28 minutes and the displayed reference-point air kerma is 3.2 Gy. You notice the C-arm is positioned close to his skin, the collimator is wide open, and the technologist steps on the pedal while the team repositions the patient and adjusts drapes. The room is crowded with six staff. You are 10 weeks pregnant and have not formally declared the pregnancy. Mr. D's skin at the beam entrance looks slightly pink.
1. What radiation safety concerns require immediate action, and how do you raise them without derailing the procedure?
Read the worked answer
What is wrong: fluoro is being used during repositioning (no one needs continuous imaging of a moving patient), the field is uncollimated, the source is close to the patient, and six people are in the room during exposures.
Speak up in real time, briefly and concretely. A structured phrase works better than a lecture: "Pause a second - can we use last image hold while we move him?" Then ask the operator to collimate to the region of interest and switch to pulsed low-dose and remove magnification.
Apply time–distance–shielding:
- Minimize total beam-on time.
- Step back when possible - doubling distance cuts exposure to roughly a quarter.
- Lead apron and thyroid shield for everyone remaining in the room; dosimeter at the collar outside the apron.
- Nonessential staff step out or behind a shield.
Dose: 3.2 Gy reference-point air kerma is above the ~2 Gy threshold for early transient erythema. Notify the interventionalist, report to the radiation safety officer, and document the dose and beam entry location. Do not continue silently to finish the case.
2. How do you handle your own pregnancy and dosimetry, given that you have not declared it?
Read the worked answer
Declaration is voluntary and confidential. You can raise it with occupational health or the radiation safety officer without announcing it to the whole room. You are entitled to know your dose before deciding.
If you do declare:
- Fetal dose guidance is typically 0.5 mSv per month and 5 mSv total for the declared pregnant worker - a limit, not a reason to stop working.
- Request a second badge worn at the waist under the apron to estimate fetal dose.
- Wear an apron of at least 0.5 mm lead equivalent; stay out of the room during exposures when your role allows, and maximize distance when it does not.
Reasoning: this is a risk-management conversation, not an emergency. The immediate patient-safety issue (the ongoing dose creep) still needs to be addressed today regardless of your decision; your pregnancy status does not require you to stay silent about the case or to leave the profession.
3. What follow-up does Mr. D need regarding skin dose, and what do you document?
Read the worked answer
Document: cumulative air kerma, fluoroscopy time, beam entry location(s), and the fact that the threshold for deterministic skin effects may have been exceeded. Record who was notified.
Education and follow-up:
- Explain that a skin reaction is possible and may be delayed.
- Warn about redness, swelling, blistering, hair loss, or a burning sensation in the treated area, and tell him who to call.
- Arrange clinical follow-up in roughly 10–14 days, since early transient erythema can appear within hours to days and more significant injury at 2–4 weeks.
The broader lesson: deterministic effects are dose- and area-dependent and are preventable, so any future procedure on the same region needs dose planning to avoid overlapping fields. Report the event per policy so the department can review technique - this is a system-learning case, not just one patient's problem.